GlassScriptIntera
Payments companies reported to CMS as associated with Intera. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Intera, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Intera
These are the largest totals companies reported as associated with Intera. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Louise Catherine Connell | New York, NY | Medical Oncology | $24,851.39 |
| Jason Castellanos | Philadelphia, PA | Surgery | $23,843.89 |
| Chandrasekhar Padmanabhan | Nashville, TN | Surgical Oncology | $19,661.09 |
| Devika Rao | Bronx, NY | Medical Oncology | $14,749.99 |
| Cornelius Thiels | Rochester, MN | Surgery | $11,466.52 |
| Jonathan Mizrahi | Saint Louis, MO | Hematology & Oncology | $7,429.84 |
| Nicholas Hornstein | Houston, TX | Internal Medicine | $6,296.68 |
| Eric Christenson | Baltimore, MD | Hematology & Oncology | $5,765.50 |
| Nancy Kemeny | New York, NY | Medical Oncology | $5,250.00 |
| David Brauer | Minneapolis, MN | Surgical Oncology | $5,202.36 |
Prescribed Intera?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.